Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04262388
Brief Title: A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation (DOME)

First Submitted : February 5, 2020
First Submitted that Met QC Criteria : February 7, 2020
First Posted : February 10, 2020

Last Update Submitted that Met QC Criteria : November 13, 2020
Last Update Posted : November 17, 2020